Skip to main content
SpringerLink
Log in

Erectile Dysfunction in Salvage Prostate Cancer Therapies

  • Chapter
  • First Online:
Salvage Therapy for Prostate Cancer

  • 334 Accesses

Abstract

Salvage therapy for prostate cancer is indicated in the context of disease recurrence. The options for salvage depend on the initial treatment modality used. The primary aim is oncological clearance. All treatments for prostate cancer run the risk of affecting sexual function, and salvage therapy can lead to further impairment. Here we will explore the extent to which sexual function is impacted after salvage focal or whole gland treatment, and review the evidence regarding whether certain types of salvage treatment have a greater effect on sexual function than others.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Singer PA, Tasch ES, Stocking C, Rubin S, Siegler M, Weichselbaum R. Sex or survival: trade-offs between quality and quantity of life. J Clin Oncol. 1991 Feb;9(2):328–34.

    Article  CAS  PubMed  Google Scholar 

  2. Agarwal PK, Sadetsky N, Konety BR, Resnick MI, Carroll PR. Treatment failure after primary and salvage therapy for prostate cancer. Cancer. 2008 Jan 15;112(2):307–14.

    Article  PubMed  Google Scholar 

  3. Marconi L, et al. MP78-12 Robotic assisted radical prostatectomy after focal therapy: oncological and functional outcomes. J Urol. 2019; https://doi.org/10.1097/01.JU.0000557344.17080.9b.

  4. Masterson TA, Stephenson AJ, Scardino PT, Eastham JA. Recovery of erectile function after salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Urology. 2005 Sep;66(3):623–6.

    Article  PubMed  Google Scholar 

  5. Yuh B, Ruel N, Muldrew S, Mejia R, Novara G, Kawachi M, et al. Complications and outcomes of salvage robot-assisted radical prostatectomy: a single-institution experience. BJU Int. 2014;113(5):769–76.

    Article  PubMed  Google Scholar 

  6. Robinson JW, Donnelly BJ, Siever JE, Saliken JC, Ernst SD, Rewcastle JC, et al. A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer. Cancer [Internet]. 2009 Oct 15;115(20):4695–704.

    Article  PubMed  Google Scholar 

  7. Onik G, Narayan P, Vaughan D, Dineen M, Brunelle R. Focal ‘Nerve-Sparing’ cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency adult urology. Urology. 2002;60:109–14.

    Article  PubMed  Google Scholar 

  8. de Castro Abreu AL, Bahn D, Leslie S, Shoji S, Silverman P, Desai MM, et al. Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy. BJU Int. 2013 Aug;112(3):298–307.

    Article  PubMed  Google Scholar 

  9. Eisenberg ML, Shinohara K. Partial Salvage Cryoablation of the prostate for recurrent prostate cancer after radiotherapy failure. Urology [Internet]. 2008 Dec;72(6):1315–8.

    Article  PubMed  Google Scholar 

  10. Lian H, Yang R, Lin T, Wang W, Zhang G, Guo H. Salvage cryotherapy with third-generation technology for locally recurrent prostate cancer after radiation therapy. Int Urol Nephrol. 2016 Sep 1;48(9):1461–6.

    Article  CAS  PubMed  Google Scholar 

  11. Ismail M, Ahmed S, Kastner C, Davies J. Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients. BJU Int. 2007 Oct;100(4):760–4.

    Article  PubMed  Google Scholar 

  12. Valerio M, Ahmed HU, Emberton M, Lawrentschuk N, Lazzeri M, Montironi R, et al. The role of focal therapy in the management of localised prostate cancer: a systematic review. Eur Urol. 2014;66(4):732–51.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Yap T, Ahmed HU, Hindley RG, Guillaumier S, McCartan N, Dickinson L, et al. The effects of focal therapy for prostate cancer on sexual function: a combined analysis of three prospective trials. Eur Urol. 2016 May;69(5):844–51.

    Article  PubMed  Google Scholar 

  14. Colombel M, Poissonnier L, Martin X, Gelet A. Clinical results of the prostate HIFU project. Eur Urol Suppl. 2006 Apr;5(6):491–4.

    Article  Google Scholar 

  15. Ganzer R, Fritsche H-M, Brandtner A, Bründl J, Koch D, Wieland WF, et al. Fourteen-year oncological and functional outcomes of high-intensity focused ultrasound in localized prostate cancer. BJU Int. 2013 Aug;112(3):322–9.

    Article  PubMed  Google Scholar 

  16. Montorsi F, Guazzoni G, Strambi LF, et al. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J Urol. 1997;4(158):1408–10.

    Google Scholar 

  17. Warmuth M, Johansson T, Mad P. Systematic review of the efficacy and safety of high-intensity focussed ultrasound for the primary and salvage treatment of prostate cancer. Eur Urol. 2010;58:803–15.

    Article  PubMed  Google Scholar 

  18. Chalasani V, Martinez CH, Lim D, Chin J. Salvage HIFU for recurrent prostate cancer after radiotherapy. Prostate Cancer Prostatic Dis. 2009;12:124–9.

    Article  CAS  PubMed  Google Scholar 

  19. Mallick S., DAFYLTSBH. High-intensity focused ultrasound as a salvage therapy for patients having failed radiation therapy as a primary treatment for prostate cancer. Prostate Cancer Symposium. 2007;168.

    Google Scholar 

  20. Thueroff S., KKCC. 10 years high intensity focused ultrasound (HIFU) as local treatment of prostate cancer: profile of side effects. AUA Annual Meeting. 2006;1133.

    Google Scholar 

  21. Lacy JM, Wilson WA, Bole R, Chen L, Meigooni AS, Rowland RG, et al. Salvage brachytherapy for biochemically recurrent prostate cancer following primary brachytherapy. Prostate Cancer. 2016;2016:1–9.

    Article  CAS  Google Scholar 

  22. Yamada Y, Okihara K, Iwata T, Masui K, Kamoi K, Yamada K, et al. Salvage brachytherapy for locally recurrent prostate cancer after external beam radiotherapy. Asian J Androl. 2015 Nov 1;17(6):899–903.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Mahmood J, Shamah AA, Creed TM, Pavlovic R, Matsui H, Kimura M, et al. Radiation-induced erectile dysfunction: Recent advances and future directions. Adv Radiat Oncol. 2016;1:161–9.

    Article  PubMed  PubMed Central  Google Scholar 

  24. van Stam MA, Aaronson NK, Pos FJ, Bosch JLHR, Kieffer JM, Tillier CN, et al. The effect of salvage radiotherapy and its timing on the health-related quality of life of prostate cancer patients. Eur Urol. 2016;70(5):751–7.

    Article  PubMed  Google Scholar 

  25. Olsson CE, Alsadius D, Pettersson N, Tucker SL, Wilderäng U, Johansson KA, et al. Patient-reported sexual toxicity after radiation therapy in long-term prostate cancer survivors. British J Cancer. 2015 Sep 1;113(5):802–8.

    Article  CAS  Google Scholar 

  26. Fuller D, Wurzer J, Shirazi R, Bridge S, Law J, Crabtree T, et al. Retreatment for local recurrence of prostatic carcinoma after prior therapeutic irradiation: efficacy and toxicity of HDR-like SBRT. Int J Radiat Oncol Biol Phys. 2020 Feb 1;106(2):291–9.

    Article  CAS  PubMed  Google Scholar 

  27. Gandaglia G, Fossati N, Karnes RJ, Boorjian SA, Colicchia M, Bossi A, et al. Use of concomitant androgen deprivation therapy in patients treated with early salvage radiotherapy for biochemical recurrence after radical prostatectomy: long-term results from a large, multi-institutional series. Eur Urol. 2018 Apr 1;73(4):512–8.

    Article  PubMed  Google Scholar 

  28. Schwartz EJ, Wong P, Graydon RJ. Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol [Internet]. 2004 Feb;171(2):771–4.

    Article  PubMed  Google Scholar 

  29. Mulhall JP, Slovick R, Hotaling J, Aviv N, Valenzuela R, Waters WB, et al. Erectile dysfunction after radical prostatectomy: hemodynamic profiles and their correlation with the recovery of erectile function. J Urol. 2002 Mar;167(3):1371–5.

    Article  PubMed  Google Scholar 

  30. Salonia A, Burnett AL, Graefen M, Hatzimouratidis K, Montorsi F, Mulhall JP, et al. Prevention and management of postprostatectomy sexual dysfunctions part 2: recovery and preservation of erectile function, sexual desire, and orgasmic function. Eur Urol. 2012 Aug;62(2):273–86.

    Article  PubMed  Google Scholar 

  31. Kirby MG, White ID, Butcher J, Challacombe B, Coe J, Grover L, et al. Development of UK recommendations on treatment for post-surgical erectile dysfunction. Int J Clin Pract. 2014 May;68(5):590–608.

    Article  CAS  PubMed  Google Scholar 

  32. Pace G, del Rosso A, Vicentini C. Penile rehabilitation therapy following radical prostatectomy. Disabil Rehabil [Internet]. 2010 Jan 15;32(14):1204–8.

    Article  PubMed  Google Scholar 

  33. Mulhall JP, Parker M, Waters BW, Flanigan R. The timing of penile rehabilitation after bilateral nerve-sparing radical prostatectomy affects the recovery of erectile function. BJU Int. 2010a Jan;105(1):37–41.

    Google Scholar 

  34. Nandipati K, Raina R, Agarwal A, Zippe CD. Early combination therapy: intracavernosal injections and sildenafil following radical prostatectomy increases sexual activity and the return of natural erections. Int J Impot Res. 2006 Sep 16;18(5):446–51.

    Article  CAS  PubMed  Google Scholar 

  35. Raina R, Agarwal A, Ausmundson S, Lakin M, Nandipati KC, Montague DK, et al. Early use of vacuum constriction device following radical prostatectomy facilitates early sexual activity and potentially earlier return of erectile function. Int J Impot Res. 2006 Jan 18;18(1):77–81.

    Article  CAS  PubMed  Google Scholar 

  36. Mulhall JP, Bella AJ, Briganti A, McCullough A, Brock G. Erectile function rehabilitation in the radical prostatectomy patient. J Sex Med [Internet]. 2010b Apr;7(4):1687–98.

    Article  PubMed  Google Scholar 

  37. Kovanecz I, Rambhatla A, Ferrini MG, Vernet D, Sanchez S, Rajfer J, et al. Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection. BJU Int [Internet]. 2007 Sep 20;0(0):070921231855003.

    Google Scholar 

  38. Özden E, Öztürk B, Koşan M, Tezel GG, Aki FT, Gür S, et al. Effect of sildenafil citrate on penile weight and physiology of cavernous smooth muscle in a post–radical prostatectomy model of erectile dysfunction in rats. Urology. 2011 Mar;77(3):761.e1–7.

    Article  Google Scholar 

  39. Sirad F, Hlaing S, Kovanecz I, Artaza JN, Garcia LA, Rajfer J, et al. Sildenafil promotes smooth muscle preservation and ameliorates fibrosis through modulation of extracellular matrix and tissue growth factor gene expression after bilateral cavernosal nerve resection in the rat. J Sex Med. 2011 Apr;8(4):1048–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Lysiak JJ, Yang S-K, Klausner AP, Son H, Tuttle JB, Steers WD. Tadalafil increases Akt and extracellular signal-regulated kinase 1/2 activation, and prevents apoptotic cell death in the penis following denervation. J Urol. 2008 Feb;179(2):779–85.

    Article  CAS  PubMed  Google Scholar 

  41. Montorsi F, Brock G, Stolzenburg J-U, Mulhall J, Moncada I, Patel HRH, et al. Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT). Eur Urol. 2014 Mar;65(3):587–96.

    Article  CAS  PubMed  Google Scholar 

  42. Gontero P, Fontana F, Bagnasacco A, Panella M, Kocjancic E, Pretti G, et al. Is there an optimal time for intracavernous prostaglandin e1 rehabilitation following nonnerve sparing radical prostatectomy? results from a hemodynamic prospective study. J Urol. 2003 Jun;169(6):2166–9.

    Article  PubMed  Google Scholar 

  43. Köhler TS, Pedro R, Hendlin K, Utz W, Ugarte R, Reddy P, et al. A pilot study on the early use of the vacuum erection device after radical retropubic prostatectomy. BJU Int. 2007 Oct;100(4):858–62.

    Article  PubMed  Google Scholar 

  44. Hellstrom WJG, Montague DK, Moncada I, Carson C, Minhas S, Faria G, et al. Implants, mechanical devices, and vascular surgery for erectile dysfunction. J Sex Med. 2010 Jan;7(1):501–23.

    Article  PubMed  Google Scholar 

  45. Bettocchi C, Palumbo F, Spilotros M, Lucarelli G, Palazzo S, Battaglia M, et al. Patient and partner satisfaction after AMS inflatable penile prosthesis implant. J Sex Med. 2010 Jan;7(1):304–9.

    Article  PubMed  Google Scholar 

  46. Menard J, Tremeaux J-C, Faix A, Pierrevelcin J, Staerman F. Erectile function and sexual satisfaction before and after penile prosthesis implantation in radical prostatectomy patients: a comparison with patients with vasculogenic erectile dysfunction. J Sex Med. 2011 Dec;8(12):3479–86.

    Article  PubMed  Google Scholar 

  47. Titta M, Tavolini IM, Moro FD, Cisternino A, Bassi P. Original research—psychology: sexual counseling improved erectile rehabilitation after non-nerve-sparing radical retropubic prostatectomy or cystectomy—results of a randomized prospective study. J Sex Med [Internet]. 2006 Mar;3(2):267–73.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Guy’s & St. Thomas’ Hospital NHS Trust, London, UK

    Raveen Sandher & Majid Shabbir

Authors
  1. Raveen Sandher
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Majid Shabbir
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Majid Shabbir .

Editor information

Editors and Affiliations

  1. Southend University Hospital NHS Foundation Trust, Southend, UK

    Sanchia S. Goonewardene

  2. North Bristol NHS Foundation Trust, Bristol, UK

    Raj Persad

  3. Harvard University, Boston, MA, USA

    Karen Ventii

  4. Department of Urology, Crouse Hospital, Syracuse, NY, USA

    David Albala

  5. Royal Marsden Hospital, London, UK

    Declan Cahill

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sandher, R., Shabbir, M. (2021). Erectile Dysfunction in Salvage Prostate Cancer Therapies. In: Goonewardene, S.S., Persad, R., Ventii, K., Albala, D., Cahill, D. (eds) Salvage Therapy for Prostate Cancer. Springer, Cham. https://doi.org/10.1007/978-3-030-57181-8_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-57181-8_21

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-57180-1

  • Online ISBN: 978-3-030-57181-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation